Drug · DIN 02568942
RANVU
SINGLE-USE VIAL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since June 10, 2026.
- Drug Identification Number (DIN)
- 02568942
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Intravitreal
- Therapeutic class (ATC)
- Ranibizumab S01LA04
- Class
- Human
- Record last updated
- August 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RANIBIZUMAB | 10 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 10, 2026: NOC 37685New Drug Submission (NDS)
Other DINs named RANVU
- DIN 02568950 · Approved